Table 3.

Presentation of significant differences of OSAS indices, inflammatory mediators, and selected lymphocyte subpopulations between patients in relation to obesity and metabolic syndrome.

		Obesity (n = 27)	Nonobese (n = 21)	p	MS (n = 26)	Without MS (n = 22)	p
AHI	h−1	62.7 39.4–71.6	42.4 34.0–51.3	0.002	46 39–72	46 34–63	NS
SpO2 min	%	74.0 67.0–79.0	81.0 78.5–85.5	0.0002	75 68–80	80 77–82	0.038
CRP	mg/dL	3.6 1.4–7.1	1.0 0.6–2.2	0.002	3.6 1.6–5.5	1 0.6–2.1	0.002
WBC	×103/μL	7.4 6.0–9.1	6.5 5.6–7.2	0.04	6.9 6–8.9	6.7 5.3–7.4	NS
Lymphocytes B	%	6.5 5.4–8.5	10.5 6.4–12.4	0.005	7.0 5.4–10	9.6 6.7–12.4	NS
NK cells	n/μL	333 244–474	209 126–294	0.006	329 209–474	258 149–337	0.03
NKT-like cells	n/μL	111 58–195	55 32–123	0.02	103 52–183	88 35–179	NS
CD3+/HLA DR+	n/μL	149 85–242	113 55–158	0.03	162 81–245	113 68–153	NS

AHI: apnea/hypopnea index; SpO₂: peripheral capillary oxygen saturation; WBC: white blood cells; MS: metabolic syndrome.